A Proposal to Standardize Reporting Units for Fecal Immunochemical Tests for Hemoglobin

被引:132
作者
Fraser, Callum G. [1 ]
Allison, James E. [2 ,3 ]
Halloran, Stephen P. [4 ]
Young, Graeme P. [5 ]
机构
[1] Univ Dundee, Ctr Res Canc Prevent & Screening, Dundee DD1 9SY, Scotland
[2] Univ Calif San Francisco, Div Gastroenterol, San Francisco, CA 94143 USA
[3] Kaiser Permanente No Calif Div Res, Oakland, CA USA
[4] Royal Surrey Cty Hosp NHS Fdn Trust, Bowel Canc Screening So Programme Hub, Guildford, Surrey, England
[5] Flinders Univ S Australia, Ctr Canc Prevent & Control, Adelaide, SA 5001, Australia
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2012年 / 104卷 / 11期
关键词
OCCULT BLOOD-TEST; CANCER SCREENING-PROGRAM; COLORECTAL-CANCER; PERFORMANCE; COLONOSCOPY; NEOPLASIA; UPDATE;
D O I
10.1093/jnci/djs190
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fecal immunochemical tests for hemoglobin are replacing traditional guaiac fecal occult blood tests in population screening programs for many reasons. However, the many available fecal immunochemical test devices use a range of sampling methods, differ with regard to hemoglobin stability, and report hemoglobin concentrations in different ways. The methods for sampling, the mass of feces collected, and the volume and characteristics of the buffer used in the sampling device also vary among fecal immunochemical tests, making comparisons of test performance characteristics difficult. Fecal immunochemical test results may be expressed as the hemoglobin concentration in the sampling device buffer and, sometimes, albeit rarely, as the hemoglobin concentration per mass of feces. The current lack of consistency in units for reporting hemoglobin concentration is particularly problematic because apparently similar hemoglobin concentrations obtained with different devices can lead to very different clinical interpretations. Consistent adoption of an internationally accepted method for reporting results would facilitate comparisons of outcomes from these tests. We propose a simple strategy for reporting fecal hemoglobin concentration that will facilitate the comparison of results between fecal immunochemical test devices and across clinical studies. Such reporting is readily achieved by defining the mass of feces sampled and the volume of sample buffer (with confidence intervals) and expressing results as micrograms of hemoglobin per gram of feces. We propose that manufacturers of fecal immunochemical tests provide this information and that the authors of research articles, guidelines, and policy articles, as well as pathology services and regulatory bodies, adopt this metric when reporting fecal immunochemical test results.
引用
收藏
页码:810 / 814
页数:5
相关论文
共 34 条
[21]   High yield of colorectal neoplasia detected by colonoscopy following a positive faecal occult blood test in the NHS Bowel Cancer Screening Programme [J].
Lee, Thomas J. W. ;
Clifford, Gayle M. ;
Rajasekhar, Praveen ;
Rutter, Matthew D. ;
Kometa, Simon ;
Ritchie, Mary C. ;
Waddup, Greg ;
Nylander, David ;
McNally, Richard J. Q. ;
Rees, Colin J. .
JOURNAL OF MEDICAL SCREENING, 2011, 18 (02) :82-86
[22]   Optimizing Colorectal Cancer Screening by Getting FIT Right [J].
Levin, Theodore R. .
GASTROENTEROLOGY, 2011, 141 (05) :1551-1555
[23]   Stool form scale as a useful guide to intestinal transit time [J].
Lewis, SJ ;
Heaton, KW .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1997, 32 (09) :920-924
[24]   The effect of fecal occult-blood screening on the incidence of colorectal cancer [J].
Mandel, JS ;
Church, TR ;
Bond, JH ;
Ederer, F ;
Geisser, MS ;
Mongin, SJ ;
Snover, DC ;
Schuman, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) :1603-1607
[25]  
McDonald PJ, 2012, CLIN CHEM L IN PRESS, V50
[26]   Do new concepts for deriving permissible limits for analytical imprecision and bias have any advantages over existing consensus? [J].
Petersen, Per Hyltoft ;
Sandberg, Sverre ;
Fraser, Callum G. .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (04) :637-640
[27]  
Segnan N., 2010, European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis-First Edition
[28]  
US Department of Health and Human Services, 2007, REV CRIT ASS QUAL FE
[29]   Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme [J].
van Rossum, L. G. M. ;
van Rijn, A. F. ;
Laheij, R. J. F. ;
van Oijen, M. G. H. ;
Fockens, P. ;
Jansen, J. B. M. J. ;
Verbeek, A. L. M. ;
Dekker, E. .
BRITISH JOURNAL OF CANCER, 2009, 101 (08) :1274-1281
[30]   Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population [J].
van Rossum, Leo G. ;
van Rijn, Anne F. ;
Laheij, Robert J. ;
van Oijen, Martijn G. ;
Fockens, Paul ;
van Krieken, Han H. ;
Verbeek, Andre L. ;
Jansen, Jan B. ;
Dekker, Evelien .
GASTROENTEROLOGY, 2008, 135 (01) :82-90